Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population.

Braden Millan,Rodney H Breau,Ranjeeta Mallick,Lori Wood,Ricardo Rendon,Antonio Finelli,Alan I So,Luke T Lavallée,Frédéric Pouliot,Bimal Bhindi,Daniel Heng,Darrel Drachenberg,Simon Tanguay,Lucas Dean,Naveen S Basappa,Jean-Baptiste Lattouf,George Bjarnason,Aly-Khan Lalani,Anil Kapoor

Urologic oncology（2023）

引用 0|浏览17

暂无评分

摘要

Patients in adjuvant trials were younger and healthier with longer CSS and OS in comparison to those not included in adjuvant trials. These findings may have implications when we generalize trial results to real world patients.

查看译文

关键词

Renal cell carcinoma, Adjuvant therapy, Clinical trials

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要